Insulin glargine and lixisenatide Subcutaneous and Midazolam Injection Hospira
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Midazolam Injection Hospira and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: midazolam
Brand name: Versed, Nayzilam
Synonyms: Midazolam
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Midazolam nasal
- Insulin glargine and lixisenatide Subcutaneous-Midazolam Nasal Spray
- Insulin glargine and lixisenatide Subcutaneous-Midazolam Syrup
- Insulin glargine and lixisenatide Subcutaneous-Midodrine
- Insulin glargine and lixisenatide Subcutaneous-Midodrine Hydrochloride
- Insulin glargine and lixisenatide Subcutaneous-Midol
- Midazolam Injection Hospira-Insulin glargine, recombinant Subcutaneous
- Midazolam Injection Hospira-Insulin glulisine
- Midazolam Injection Hospira-Insulin Glulisine (Cartridges and Pens)
- Midazolam Injection Hospira-Insulin Glulisine (Vials)
- Midazolam Injection Hospira-Insulin glulisine Subcutaneous
- Midazolam Injection Hospira-Insulin human inhaled Inhalation